Warning! GuruFocus detected
1 Severe warning sign
with TPST.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Tempest Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US87978U1088
Description
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.25 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 1.55 | |||||
| Debt-to-EBITDA | -0.53 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 14.2 | |||||
| 3-Year EPS without NRI Growth Rate | 12.9 | |||||
| 3-Year FCF Growth Rate | 14.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.09 | |||||
| 9-Day RSI | 30.89 | |||||
| 14-Day RSI | 35.18 | |||||
| 3-1 Month Momentum % | -3.01 | |||||
| 6-1 Month Momentum % | -42.19 | |||||
| 12-1 Month Momentum % | -79.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.69 | |||||
| Quick Ratio | 1.69 | |||||
| Cash Ratio | 1.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.2 | |||||
| Shareholder Yield % | -121.61 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -238.04 | |||||
| ROA % | -90.62 | |||||
| ROIC % | -187.2 | |||||
| 3-Year ROIIC % | -73.05 | |||||
| ROC (Joel Greenblatt) % | -324.27 | |||||
| ROCE % | -121.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.66 | |||||
| Price-to-Tangible-Book | 1.66 | |||||
| EV-to-EBIT | -0.43 | |||||
| EV-to-Forward-EBIT | -0.22 | |||||
| EV-to-EBITDA | -0.43 | |||||
| EV-to-Forward-EBITDA | -0.22 | |||||
| EV-to-FCF | -0.64 | |||||
| Price-to-Net-Current-Asset-Value | 17.87 | |||||
| Earnings Yield (Greenblatt) % | -232.56 | |||||
| FCF Yield % | -107.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TPST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tempest Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.5 | ||
| Beta | -3.05 | ||
| 3-Year Sharpe Ratio | 0.43 | ||
| 3-Year Sortino Ratio | 4.82 | ||
| Volatility % | 52.16 | ||
| 14-Day RSI | 35.18 | ||
| 14-Day ATR ($) | 0.050215 | ||
| 20-Day SMA ($) | 0.81517 | ||
| 12-1 Month Momentum % | -79.3 | ||
| 52-Week Range ($) | 0.6986 - 6 | ||
| Shares Outstanding (Mil) | 43.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tempest Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tempest Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tempest Therapeutics Inc Frequently Asked Questions
What is Tempest Therapeutics Inc(TPST)'s stock price today?
The current price of TPST is $0.71. The 52 week high of TPST is $6.00 and 52 week low is $0.70.
When is next earnings date of Tempest Therapeutics Inc(TPST)?
The next earnings date of Tempest Therapeutics Inc(TPST) is 2025-05-09 Est..
Does Tempest Therapeutics Inc(TPST) pay dividends? If so, how much?
Tempest Therapeutics Inc(TPST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers